Celularity Inc.
CELUNASDAQHealthcare● Active
$0.81
$-0.06(-6.92%)
Market Cap$19528914
P/E Ratio—
52W High$4.35
52W Low$0.71
Celularity Inc. (CELU) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CELU · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $26.55M | $54.22M | $22.77M | $17.98M | $21.34M |
| Cost of Revenue | $6.36M | $14.99M | $16.02M | $19.66M | $9.65M |
| Gross Profit | $20.19M | $39.23M | $6.75M | ($1.69M) | $11.68M |
| Gross Margin %(computed) | 76.04% | 72.36% | 29.66% | -9.40% | 54.76% |
| Operating Expenses | |||||
| R&D Expenses | $15.03M | $17.39M | $30.46M | $78.36M | $88.35M |
| G&A Expenses | $0.00M | $58.62M | $50.53M | $65.86M | $0.00M |
| Total Operating Expenses | $81.50M | $77.59M | $199.04M | $23.91M | $120.74M |
| Operating Income | ($61.31M) | ($38.36M) | ($192.29M) | ($25.60M) | ($109.06M) |
| Operating Margin %(computed) | -230.92% | -70.75% | -844.44% | -142.42% | -511.17% |
| Interest Income | $0.26M | $0.33M | $0.32M | $0.36M | $0.33M |
| Interest Expense | $6.75M | $6.26M | $3.02M | $0.00M | $3.17M |
| Income Before Tax | ($91.71M) | ($57.89M) | ($196.28M) | $14.21M | ($100.10M) |
| Income Tax Expense | $0.00M | $0.00M | $0.01M | $0.01M | $0.02M |
| Net Income | ($91.80M) | ($57.89M) | ($196.29M) | $14.19M | ($100.12M) |
| Net Margin %(computed) | -345.76% | -106.77% | -862.04% | 78.95% | -469.27% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.59 | $-2.64 | $-11.02 | $1.01 | $-7.87 |
| Wtd Avg Shares | 25.60M | 21.89M | 17.81M | 13.99M | 12.73M |
| EBITDA | ($77.66M) | ($43.71M) | ($183.95M) | ($138.83M) | ($88.11M) |
| EBITDA Margin %(computed) | -292.52% | -80.61% | -807.81% | -772.36% | -412.98% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Celularity Inc. data
About Celularity Inc. (CELU) Income Statement
Celularity Inc. (CELU) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CELU reported revenue of $0.03B, gross profit of $0.02B (gross margin 76.04%), and net income of ($0.09B) — a net profit margin of -345.76%.
Frequently asked questions
CELU · 4 questionsCelularity Inc. (CELU) reported revenue of $0.03B for 2025, down 51.0% year-over-year.
CELU revenueCELU salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09